AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $724,000 | +51.1% | 47,884 | -25.1% | 0.00% | +33.3% |
| Q2 2022 | $479,000 | +262.9% | 63,919 | +340.2% | 0.00% | +200.0% |
| Q1 2022 | $132,000 | -76.4% | 14,519 | -81.8% | 0.00% | 0.0% |
| Q4 2021 | $560,000 | +188.7% | 79,707 | +369.6% | 0.00% | 0.0% |
| Q3 2021 | $194,000 | -74.3% | 16,975 | -64.0% | 0.00% | -66.7% |
| Q2 2021 | $755,000 | +8.6% | 47,187 | -8.2% | 0.00% | -40.0% |
| Q4 2020 | $695,000 | +67.9% | 51,417 | +46.2% | 0.01% | -16.7% |
| Q3 2020 | $414,000 | +48.9% | 35,157 | +86.8% | 0.01% | +50.0% |
| Q2 2020 | $278,000 | +20.9% | 18,817 | +10.3% | 0.00% | -33.3% |
| Q1 2020 | $230,000 | -88.3% | 17,066 | -79.0% | 0.01% | -50.0% |
| Q4 2019 | $1,968,000 | -38.3% | 81,405 | -50.9% | 0.01% | -57.1% |
| Q3 2019 | $3,188,000 | +257.8% | 165,871 | +450.1% | 0.03% | +211.1% |
| Q2 2019 | $891,000 | -79.2% | 30,155 | -66.5% | 0.01% | -80.0% |
| Q1 2019 | $4,277,000 | +1010.9% | 90,049 | +743.4% | 0.04% | +1025.0% |
| Q4 2018 | $385,000 | -77.6% | 10,677 | -61.8% | 0.00% | -81.0% |
| Q3 2018 | $1,720,000 | +201.8% | 27,940 | +166.0% | 0.02% | +133.3% |
| Q1 2018 | $570,000 | -7.3% | 10,502 | -10.2% | 0.01% | -25.0% |
| Q2 2017 | $615,000 | +5.7% | 11,700 | -8.8% | 0.01% | -25.0% |
| Q1 2017 | $582,000 | -47.2% | 12,834 | -56.0% | 0.02% | -64.4% |
| Q4 2016 | $1,103,000 | +94.2% | 29,144 | +93.7% | 0.04% | +18.4% |
| Q3 2016 | $568,000 | – | 15,043 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|